Effect of aspirin on HIV disease progression among HIV-infected individuals initiating antiretroviral therapy: study protocol for a randomised controlled trial

Código QR

Effect of aspirin on HIV disease progression among HIV-infected individuals initiating antiretroviral therapy: study protocol for a randomised controlled trial

Guardado en:

Detalles Bibliográficos
Autores principales:	Tosi Mwakyandile, Eligius Lyamuya, Ferdinand Mugusi, Candida Moshiro, Grace Shayo, Sabina Mugusi, Bruno Sunguya, Philip Sasi
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/34c6c2be003147c496290180f52e9e3c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Factors hindering integration of care for non-communicable diseases within HIV care services in Dar es Salaam, Tanzania: The perspectives of health workers and people living with HIV.
por: Tausi Haruna, et al.
Publicado: (2021)

Integrating HIV, diabetes and hypertension services in Africa: study protocol for a cluster randomised trial in Tanzania and Uganda
por: Max Bachmann, et al.
Publicado: (2021)

Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
por: GYeon Oh, et al.
Publicado: (2021)

Timely initiation of HIV antiretroviral therapy in Haiti 20042018: a retrospective cohort study
por: Nancy Puttkammer, et al.
Publicado: (2021)

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
por: Timothy J Henrich, et al.
Publicado: (2017)

Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?
por: Simon P Johnstone-Robertson, et al.
Publicado: (2011)

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes
por: Monica Gandhi, et al.
Publicado: (2021)

THE SIGNIFICANCE OF THE HIV RESISTANCE ANALYSIS IN ANTIRETROVIRAL THERAPY
por: D. E. Valutite, et al.
Publicado: (2018)

Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.
por: Hind Satti, et al.
Publicado: (2012)

The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.
por: Bernhard Kerschberger, et al.
Publicado: (2012)

Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapy
por: Junfeng Wang, et al.
Publicado: (2021)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq G, et al.
Publicado: (2018)

Uncontrolled Hypertension amongst People Living with HIV on Antiretroviral Therapy at an Urban HIV Clinic in Swaziland
por: O. Jimoh, et al.
Publicado: (2017)

Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration.
por: Faroudy Boufassa, et al.
Publicado: (2014)

Incidence and Predictors of Initial Antiretroviral Therapy Regimen Change Among HIV-Infected Adults Receiving Antiretroviral Therapy at Arba Minch General Hospital, Southern Ethiopia
por: Gebremichael MA, et al.
Publicado: (2020)

HIV and antiretroviral treatment knowledge gaps and psychosocial burden among persons living with HIV in Lima, Peru.
por: Rafaella Navarro, et al.
Publicado: (2021)

Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
por: Matthew Weichseldorfer, et al.
Publicado: (2021)

Quality of life of people living with HIV and AIDS and antiretroviral therapy
por: Oguntibeju OO
Publicado: (2012)

Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
por: Nadine Mayasi Ngongo, et al.
Publicado: (2021)

HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa
por: Hirasen K, et al.
Publicado: (2020)

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
por: Thomas B Campbell, et al.
Publicado: (2012)

Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia
por: Bayisa L, et al.
Publicado: (2020)

Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
por: Kanters S, et al.
Publicado: (2013)

Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
por: Nadine Mayasi Ngongo, et al.
Publicado: (2021)

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
por: Martin W G Brinkhof, et al.
Publicado: (2009)

Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon
por: William Baiye Abange, et al.
Publicado: (2021)

An optimal BMI range associated with a lower risk of mortality among HIV-infected adults initiating antiretroviral therapy in Guangxi, China
por: Junjun Jiang, et al.
Publicado: (2019)

Earlier antiretroviral initiation is independently associated with better arterial stiffness in children living with perinatally acquired HIV with sustained viral suppression in Mozambique
por: Igor S. Dobe, et al.
Publicado: (2021)

Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples
por: Haisheng Wu, et al.
Publicado: (2021)

Effects of different antiretroviral treatments on gut microbiota of hiv-infected patients
por: Villanueva-Millán, M. J.
Publicado: (2018)

Antiretroviral Treatment Failure and Associated Factors Among HIV-Infected Children on Antiretroviral Therapy: A Retrospective Study
por: Getawa S, et al.
Publicado: (2021)

HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
por: A. V. Mordyk, et al.
Publicado: (2016)

Vitamin D status and associated factors among HIV-infected children and adolescents on antiretroviral therapy in Kampala, Uganda.
por: Thereza Were Piloya, et al.
Publicado: (2021)

Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
por: Pere Domingo, et al.
Publicado: (2010)

T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy.
por: Gila Lustig, et al.
Publicado: (2021)

Economic impact of HIV and antiretroviral therapy on education supply in high prevalence regions.
por: Claire L Risley, et al.
Publicado: (2012)

Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
por: Mary F Kearney, et al.
Publicado: (2014)

Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy.
por: Lotus A van Arnhem, et al.
Publicado: (2013)

Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy
por: Medini K. Annavajhala, et al.
Publicado: (2020)

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
por: Ameya R. Kirtane, et al.
Publicado: (2018)